In vitro efficacy of potentiated egg yolk powder against Campylobacter jejuni does not correlate with in vitro efficacy.

Campylobacter jejuni is a zoonotic agent responsible for the foodborne gastroenteritis campylobacteriosis. Control of C. jejuni load in the poultry primary production is recognized as an avenue to reduce human exposure to the pathogen. As for now, no commercially applicable control methods exist at...

Full description

Bibliographic Details
Main Authors: Amina Soumaila Garba, Alexandre Thibodeau, Audrey Perron, Sylvette Laurent-Lewandowski, Ann Letellier, Philippe Fravalo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0212946
id doaj-ede59fe7a5c841df806c00dcd79f429c
record_format Article
spelling doaj-ede59fe7a5c841df806c00dcd79f429c2021-03-03T20:50:10ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-01143e021294610.1371/journal.pone.0212946In vitro efficacy of potentiated egg yolk powder against Campylobacter jejuni does not correlate with in vitro efficacy.Amina Soumaila GarbaAlexandre ThibodeauAudrey PerronSylvette Laurent-LewandowskiAnn LetellierPhilippe FravaloCampylobacter jejuni is a zoonotic agent responsible for the foodborne gastroenteritis campylobacteriosis. Control of C. jejuni load in the poultry primary production is recognized as an avenue to reduce human exposure to the pathogen. As for now, no commercially applicable control methods exist at the farm. Several studies tested egg yolk powders, potentiated or not against C. jejuni, as feed additives for chicken and suggested that the quantity and quality of the antibodies presence in the yolk are determinant factors for the full success of this approach. Unfortunately, data from these studies inconsistently showed a reduction of cecal C. jejuni carriage. Our first goal wwas to characterize (quantification by ELISA, agglutination test, bacterial antigen recognition profiles by Western blot, bactericidal effect by serum killing assays and C. jejuni mobility by soft agar migation) the antibodies extracted from egg yolk powders originating from different egg production protocols. Secondly, these powders were microencapsulated and recharacterized. Finally the protected powders were tested as a feed additive to destabilize C. jejuni colonization in an in vivo assay. Despite the in vitro results indicating the ability of the egg yolk powders to recognize Campylobacter and potentially alter its colonization of the chicken caecum, these results were not confirmed in the in vivo trial despite that specific caecal IgY directed toward Campylobacter were detected in the groups receiving the protected powders. More research is needed on Campylobacter in order to effectively control this pathogen at the farm.https://doi.org/10.1371/journal.pone.0212946
collection DOAJ
language English
format Article
sources DOAJ
author Amina Soumaila Garba
Alexandre Thibodeau
Audrey Perron
Sylvette Laurent-Lewandowski
Ann Letellier
Philippe Fravalo
spellingShingle Amina Soumaila Garba
Alexandre Thibodeau
Audrey Perron
Sylvette Laurent-Lewandowski
Ann Letellier
Philippe Fravalo
In vitro efficacy of potentiated egg yolk powder against Campylobacter jejuni does not correlate with in vitro efficacy.
PLoS ONE
author_facet Amina Soumaila Garba
Alexandre Thibodeau
Audrey Perron
Sylvette Laurent-Lewandowski
Ann Letellier
Philippe Fravalo
author_sort Amina Soumaila Garba
title In vitro efficacy of potentiated egg yolk powder against Campylobacter jejuni does not correlate with in vitro efficacy.
title_short In vitro efficacy of potentiated egg yolk powder against Campylobacter jejuni does not correlate with in vitro efficacy.
title_full In vitro efficacy of potentiated egg yolk powder against Campylobacter jejuni does not correlate with in vitro efficacy.
title_fullStr In vitro efficacy of potentiated egg yolk powder against Campylobacter jejuni does not correlate with in vitro efficacy.
title_full_unstemmed In vitro efficacy of potentiated egg yolk powder against Campylobacter jejuni does not correlate with in vitro efficacy.
title_sort in vitro efficacy of potentiated egg yolk powder against campylobacter jejuni does not correlate with in vitro efficacy.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2019-01-01
description Campylobacter jejuni is a zoonotic agent responsible for the foodborne gastroenteritis campylobacteriosis. Control of C. jejuni load in the poultry primary production is recognized as an avenue to reduce human exposure to the pathogen. As for now, no commercially applicable control methods exist at the farm. Several studies tested egg yolk powders, potentiated or not against C. jejuni, as feed additives for chicken and suggested that the quantity and quality of the antibodies presence in the yolk are determinant factors for the full success of this approach. Unfortunately, data from these studies inconsistently showed a reduction of cecal C. jejuni carriage. Our first goal wwas to characterize (quantification by ELISA, agglutination test, bacterial antigen recognition profiles by Western blot, bactericidal effect by serum killing assays and C. jejuni mobility by soft agar migation) the antibodies extracted from egg yolk powders originating from different egg production protocols. Secondly, these powders were microencapsulated and recharacterized. Finally the protected powders were tested as a feed additive to destabilize C. jejuni colonization in an in vivo assay. Despite the in vitro results indicating the ability of the egg yolk powders to recognize Campylobacter and potentially alter its colonization of the chicken caecum, these results were not confirmed in the in vivo trial despite that specific caecal IgY directed toward Campylobacter were detected in the groups receiving the protected powders. More research is needed on Campylobacter in order to effectively control this pathogen at the farm.
url https://doi.org/10.1371/journal.pone.0212946
work_keys_str_mv AT aminasoumailagarba invitroefficacyofpotentiatedeggyolkpowderagainstcampylobacterjejunidoesnotcorrelatewithinvitroefficacy
AT alexandrethibodeau invitroefficacyofpotentiatedeggyolkpowderagainstcampylobacterjejunidoesnotcorrelatewithinvitroefficacy
AT audreyperron invitroefficacyofpotentiatedeggyolkpowderagainstcampylobacterjejunidoesnotcorrelatewithinvitroefficacy
AT sylvettelaurentlewandowski invitroefficacyofpotentiatedeggyolkpowderagainstcampylobacterjejunidoesnotcorrelatewithinvitroefficacy
AT annletellier invitroefficacyofpotentiatedeggyolkpowderagainstcampylobacterjejunidoesnotcorrelatewithinvitroefficacy
AT philippefravalo invitroefficacyofpotentiatedeggyolkpowderagainstcampylobacterjejunidoesnotcorrelatewithinvitroefficacy
_version_ 1714820315242037248